These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

978 related articles for article (PubMed ID: 28615077)

  • 21. "They don't like us….": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study.
    Kumar S; Gupte HA; Isaakidis P; Mishra JK; Munjattu JF
    PLoS One; 2018; 13(8):e0203262. PubMed ID: 30161255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.
    MacArthur GJ; van Velzen E; Palmateer N; Kimber J; Pharris A; Hope V; Taylor A; Roy K; Aspinall E; Goldberg D; Rhodes T; Hedrich D; Salminen M; Hickman M; Hutchinson SJ
    Int J Drug Policy; 2014 Jan; 25(1):34-52. PubMed ID: 23973009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.
    Petersen Z; Myers B; van Hout MC; Plüddemann A; Parry C
    Harm Reduct J; 2013 Aug; 10():13. PubMed ID: 23957896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda.
    Kamusiime B; Beima-Sofie K; Chhun N; Nalumansi A; Nalukwago GK; Kasiita V; Twesige CC; Kansiime R; Muwonge TR; Kyambadde P; Kadama H; Mudiope P; Glick S; Lambdin B; Mujugira A; Heffron R
    Addict Sci Clin Pract; 2024 Feb; 19(1):13. PubMed ID: 38395940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling the impact and cost-effectiveness of non-governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine.
    Stone J; Trickey A; Walker JG; Bivegete S; Semchuk N; Sazonova Y; Varetska O; Altice FL; Saliuk T; Vickerman P
    J Int AIDS Soc; 2023 Apr; 26(4):e26073. PubMed ID: 37012669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
    Stone KA
    Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV prevention cascades for injection and sexual risk behaviors among HIV-negative people who inject drug in Iran.
    Gangi MF; Karamouzian M; Nedjat S; Rahimi-Movaghar A; Yazdani K; Shokoohi M; Mirzazadeh A
    Int J Drug Policy; 2020 Oct; 84():102868. PubMed ID: 32717706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.
    Solomon SS; Quinn TC; Solomon S; McFall AM; Srikrishnan AK; Verma V; Kumar MS; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Thomas DL; Sachdeva KS; Lucas GM; Mehta SH
    J Hepatol; 2020 Jan; 72(1):67-74. PubMed ID: 31604081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of HIV testing, drug use, and sexual behaviors in people who use drugs: findings from a community-based outreach program in Phnom Penh, Cambodia.
    Mburu G; Ngin C; Tuot S; Chhoun P; Pal K; Yi S
    Addict Sci Clin Pract; 2017 Dec; 12(1):27. PubMed ID: 29202872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services.
    Bartholomew TS; Plesons M; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; Chueng TA; Ciraldo K; Brooks J; Smith JD; Barocas JA; Tookes HE
    Addict Sci Clin Pract; 2024 Mar; 19(1):21. PubMed ID: 38528570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs.
    Yang Y; Latkin C; Luan R; Yang C
    Int J Drug Policy; 2016 Jan; 27():113-20. PubMed ID: 26123897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How far will they go? Assessing the travel distance of current and former drug users to access harm reduction services.
    Allen S; Ruiz M; O'Rourke A
    Harm Reduct J; 2015 Mar; 12():3. PubMed ID: 25889589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
    Degenhardt L; Mathers BM; Wirtz AL; Wolfe D; Kamarulzaman A; Carrieri MP; Strathdee SA; Malinowska-Sempruch K; Kazatchkine M; Beyrer C
    Int J Drug Policy; 2014 Jan; 25(1):53-60. PubMed ID: 24113623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.
    Des Jarlais DC; Nugent A; Solberg A; Feelemyer J; Mermin J; Holtzman D
    MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(48):1337-41. PubMed ID: 26655918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia.
    Butler K; Day C; Dietze P; Bruno R; Alati R; Burns L
    J Subst Abuse Treat; 2015 Nov; 58():90-4. PubMed ID: 26117080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using a programmatic mapping approach to plan for HIV prevention and harm reduction interventions for people who inject drugs in three South African cities.
    Scheibe A; Shelly S; Lambert A; Schneider A; Basson R; Medeiros N; Padayachee K; Savva H; Hausler H
    Harm Reduct J; 2017 Jun; 14(1):35. PubMed ID: 28592246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators.
    Ludwig-Barron NT; Guthrie BL; Mbogo L; Bukusi D; Sinkele W; Gitau E; Farquhar C; Monroe-Wise A
    Harm Reduct J; 2021 Dec; 18(1):133. PubMed ID: 34922548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland.
    Fraser H; Mukandavire C; Martin NK; Goldberg D; Palmateer N; Munro A; Taylor A; Hickman M; Hutchinson S; Vickerman P
    Addiction; 2018 Nov; 113(11):2118-2131. PubMed ID: 29781207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.